Search results for “TNFRSF10B” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 101 patents, we discovered top 25 key players by total patent application. Inhibrx, Inc., Dong-A ST Co., Ltd., Galaxy Biotech LLC are dominant in this area. They take 45.54% of the total patent filing.
Inhibrx, Inc.
California, United States
Patent: 21
Dong-A ST Co., Ltd.
South Korea
Patent: 11
Galaxy Biotech LLC
California, United States
Patent: 10
OncoPlex Diagnostics, Inc.
United States
Patent: 8
Academisch Ziekenhuis Maastricht
Netherlands
Patent: 5
Merck Sharp & Dohme BV
Noord-Brabant, Netherlands
Patent: 5
Human Genome Sciences, Inc.
United States
Patent: 4
Yantai Heyuanaidisi Biomedical Technology Co Ltd
Shandong Sheng, China
Patent: 4
Regents of The University of Michigan
Michigan, United States
Patent: 3
Inhibrx LP
California, United States
Patent: 3
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 42 patents applied in the last 5 years. We discover 15 most active companies in this area. The fast-growing Inhibrx, Inc., Dong-A ST Co., Ltd., Galaxy Biotech LLC take 57.14% of patent filing during this period.
Inhibrx, Inc.
California, United States
Patent: 10
Dong-A ST Co., Ltd.
South Korea
Patent: 10
Galaxy Biotech LLC
California, United States
Patent: 4
The University of Virginia Patent Foundation
United States
Patent: 3
Seoul University Industry Academic Cooperation Foundation
South Korea
Patent: 3
Inhibrx LP
California, United States
Patent: 2
Innovative Cellular Therapeutics, Inc.
United States
Patent: 1
University of Minnesota
Minnesota, United States
Patent: 1
Merck Sharp & Dohme Corp.
New Jersey, United States
Patent: 1
The Johns Hopkins University
United States
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 42 patents in last 5 years, we discover 8 new entrants. The University of Virginia Patent Foundation, Innovative Cellular Therapeutics, Inc., University of Minnesota are the most active new entrants in this area.
The University of Virginia Patent Foundation
United States
Patent: 3
Innovative Cellular Therapeutics, Inc.
United States
Patent: 1
University of Minnesota
Minnesota, United States
Patent: 1
Merck Sharp & Dohme LLC
New Jersey, United States
Patent: 1
Kunming University of Science & Technology
Yunnan Sheng, China
Patent: 1
Kyungpook National University Industry-Academic Cooperation
South Korea
Patent: 1
Merck Sharp & Dohme Corp.
New Jersey, United States
Patent: 1
Innovative Cellular Therapeutics Co., Ltd.
Shanghai Shi, China
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 63 patents, we discovered top 11 universities and scientific research institutions by total patent application. University of Groningen, National University of Ireland, The Johns Hopkins University are dominant in this area. They take 57.14% of the total patent filing.
University of Groningen
Groningen, Netherlands
Patent: 14
National University of Ireland
DUBLIN, Ireland
Patent: 11
The Johns Hopkins University
United States
Patent: 8
National University of Ireland Galway
GALWAY, Ireland
Patent: 5
Institute of Basic Medical Sciences
Beijing Shi, China
Patent: 2
University of Minnesota
Minnesota, United States
Patent: 1
Washington University in St. Louis
Missouri, United States
Patent: 1
Loma Linda University
California, United States
Patent: 1
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 1
Xiamen University
Fujian Sheng, China
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: